Cancer Injection Saves Patients Hours in Northern Ireland

Cancer patients in Northern Ireland are getting back precious hours of their lives thanks to a revolutionary new way to receive a life-saving treatment.

Keytruda, one of the world's most effective cancer drugs, can now be administered as a simple injection taking one to two minutes instead of an hour-long drip. Three of Northern Ireland's five health trusts started using the injectable version in April 2025, and Health Minister Mike Nesbitt confirmed this week that all trusts will soon offer it to suitable patients.

The change might sound small, but it's transformative for people already facing the exhaustion of cancer treatment. Instead of sitting in a hospital chair for over an hour while medicine slowly drips through an IV, patients now receive the same treatment through a quick injection every three or six weeks, depending on their diagnosis.

Keytruda works by lifting cancer's "invisibility cloak." The disease hides from our immune system by sending "stop signals" that tell our bodies not to attack. This immunotherapy drug blocks those signals, letting the immune system recognize and destroy cancer cells naturally.

The treatment has become the world's best-selling prescription medicine for good reason. Since 2015, it's helped countless patients fight multiple types of cancer. The discovery behind how it works even won two scientists the Nobel Prize for medicine in 2018.

Why This Inspires

Beyond saving patient time, the injectable version frees up hospital staff and resources to care for more people. Northern Ireland has seen record-high cancer cases recently, making every minute of clinical time more valuable.

The rollout required substantial work updating clinical protocols and managing the transition from IV bags prepared in sterile conditions to ready-to-use injections. The Western, South Eastern, and Northern trusts completed this challenging transition while minimizing waste of existing supplies.

Health Minister Nesbitt recognized the dual benefit: "saving precious time for those receiving treatment for cancer as well as releasing valuable time so clinicians can care for more people." It's a win that ripples outward, touching patients, families, healthcare workers, and future patients who will benefit from the freed-up capacity.

The injectable version became available across England and Wales this week, and Northern Ireland is keeping pace with making this advancement accessible to everyone who needs it.

Sometimes medical progress means discovering entirely new treatments, but sometimes it means making existing miracles more accessible and less burdensome for the people who need them most.